Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

New study to shed light on brain health of domestic violence victims

A new research has been initiated to investigate the lifelong consequences of domestic violence on brain health.

The Drake IPV Study, led by the University of Glasgow in collaboration with the University of Edinburgh, and funded by the Drake Foundation, will examine individuals exposed to domestic abuse, many of whom currently report a history of traumatic brain injury.


The research, overseen by Professor Willie Stewart, who leads multiple collaborative research programmes exploring outcomes from traumatic brain injury, recognises the growing awareness of the association between brain injury and increased risk of neurodegenerative disease including dementia.

The Drake Foundation has awarded funding to this important new study.

Willie Stewart, consultant neuropathologist and honorary professor at the University of Glasgow, said: “There is a need for robust investigations to better understand brain health outcomes following domestic abuse.

“Traumatic brain injury is one important risk factor contributing to risk of dementia, but there has been remarkably little research looking at the potential lifelong outcomes of trauma from intimate partner violence.“

Prof Craig Ritchie, chair of the Psychiatry of Ageing and Director of the Centre for Dementia Prevention at the University of Edinburgh, said: “The PREVENT Dementia Programme always sought to understand the contribution of all risk factors for later life dementia and while it is now well known that head injury affects the risk of dementia, we also need to understand the source of that head injury to be able to work effectively to prevent and manage this effectively.

“This funding is so critical in bringing intimate partner violence out of the shadows in terms of dementia risk.”

The researchers will look for any neuroimaging changes in the brains of individuals with a history of domestic abuse, as well as any changes that correlate with measures of exposure to traumatic brain injury, and compare these to population controls with no reported history of abuse.

Domestic abuse – or intimate partner violence – is common, with global estimates suggesting approximately 30 per cent of women over age 15 years will have been exposed to physical or sexual intimate partner violence. However, there remains a lack of research in this issue, in particular the long-term consequences for those affected.

More For You

Chemotherapy-free leukaemia treatment

The trial found that a combination of two cancer drugs, ibrutinib and venetoclax, could perform better than chemotherapy among patients with chronic lymphocytic leukaemia.

iStock

Chemotherapy-free leukaemia treatment shows promise during trial

In a breakthrough in leukaemia research, scientists in the UK have tested a chemotherapy-free approach, involving a combination of targeted drugs, which may offer better outcomes.

The new treatment could radically change the way chronic lymphocytic leukaemia (CLL), the most common form of leukaemia in adults, is treated.

Keep ReadingShow less
Wales ranked worst for second-trimester abortion access in the UK

Each year about 175 women travel from Wales to England for care

Wales ranked worst for second-trimester abortion access in the UK

A leading healthcare charity has revealed that Wales is the worst part of the United Kingdom for allowing surgical abortions for women.

Surgical abortion is the process removing pregnancy from the womb by inducing local anaesthesia, conscious sedation or general anaesthesia.

Keep ReadingShow less
The fund offers £150 per eligible child - for up to three children per household.

The fund offers £150 per eligible child - for up to three children per household.

Charity reopens funding to ease back to school financial pressures for community pharmacists

Community pharmacists struggling with the costs of their children going back to school can apply for funding from The Leverhulme Trade Charities Trust (LTCT)

The Trust is providing up to £100,000 of support to those working in a community pharmacy or are a registered pharmacist or pharmacy technician

Keep ReadingShow less
Germany's BioNTech to buy CureVac to boost cancer research

Both biotech companies have been working for years in the area of mRNA vaccines and treatments

Germany's BioNTech to buy CureVac to boost cancer research

Germany's BioNTech is buying domestic rival CureVac for $1.25 billion, bringing together two pharmaceutical firms specialised in mRNA technology with the goal of advancing cancer treatments.

BioNTech, which developed the first coronavirus vaccine to be approved in the West along with US pharmaceutical giant Pfizer, said the acquisition would "bring together complementary capabilities and leverage technologies".

Keep ReadingShow less
Amandeep Doll RPS  New Director of England

Amandeep Doll

RPS announces new director of England

Amandeep Doll has been named as the new director for England at the Royal Pharmaceutical Society (RPS).

The role of Director for England drives professional leadership for the pharmacy profession in England, and leads on national policy development and advocacy across England, in partnership with the English Pharmacy Board.

Keep ReadingShow less